Tatiana Gianni
Bologna, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Therapeutic vaccination for glioblastoma elicited by retargeted oncolytic herpes virus.
Journal: Journal for immunotherapy of cancer
Published: December 19, 2025
Gnostic and agnostic immunotherapy by tropism-retargeted herpes simplex virus without direct tumor treatment.
Journal: Journal for immunotherapy of cancer
Published: July 07, 2025
Corrigendum: Innovative retargeted oncolytic herpesvirus against nectin4-positive cancers.
Journal: Frontiers in molecular biosciences
Published: June 05, 2024
Decrease in Heparan Sulphate Binding in Tropism-Retargeted Oncolytic Herpes Simplex Virus (ReHV) Delays Blood Clearance and Improves Systemic Anticancer Efficacy.
Journal: Cancers
Published: January 11, 2024
Efficacy of Systemically Administered Retargeted Oncolytic Herpes Simplex Viruses-Clearance and Biodistribution in Naïve and HSV-Preimmune Mice.
Journal: Cancers
Published: July 18, 2023
Innovative retargeted oncolytic herpesvirus against nectin4-positive cancers.
Journal: Frontiers in molecular biosciences
Published: January 23, 2023
Genotype of Immunologically Hot or Cold Tumors Determines the Antitumor Immune Response and Efficacy by Fully Virulent Retargeted oHSV.
Journal: Viruses
Published: July 23, 2021
Halting the Spread of Herpes Simplex Virus-1: The Discovery of an Effective Dual αvβ6/αvβ8 Integrin Ligand.
Journal: Journal of medicinal chemistry
Published: May 07, 2021
Immunotherapeutic Efficacy of Retargeted oHSVs Designed for Propagation in an Ad Hoc Cell Line.
Journal: Cancers
Published: October 30, 2020
Rescue, Purification, and Characterization of a Recombinant HSV Expressing a Transgenic Protein.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: October 17, 2019
oHSV Genome Editing by Means of galK Recombineering.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: October 17, 2019
Last Updated: 09/26/2026